Manidipine
Antihypertensive drug of the calcium channel blocker class
Clinical data | |
---|---|
Trade names | Manyper, Caldine, etc. |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C35H38N4O6 |
Molar mass | 610.711 g·mol−1 |
3D model (JSmol) | |
| |
|
Manidipine is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive.
It was patented in 1982 and approved for medical use in 1990.
Simple piperazines (no additional rings) | |
---|---|
Phenylpiperazines |
|
Benzylpiperazines | |
Diphenylalkylpiperazines (benzhydrylalkylpiperazines) |
|
Pyrimidinylpiperazines | |
Pyridinylpiperazines | |
Benzo(iso)thiazolylpiperazines | |
Tricyclics (piperazine attached via side chain) |
|
Others/Uncategorized |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |